{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:01:15Z","timestamp":1773270075843,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.seizure.2016.01.020","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T14:06:31Z","timestamp":1455631591000},"page":"36-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Levocarnitine induced seizures in patients on valproic acid: A negative systematic review"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1737-0510","authenticated-orcid":false,"given":"F.A.","family":"Zeiler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Gillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2016.01.020_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.seizure.2016.01.020_bib0180","doi-asserted-by":"crossref","first-page":"g254","DOI":"10.1136\/bmj.g254","article-title":"Drug treatment of epilepsy in adults","volume":"348","author":"Schmidt","year":"2014","journal-title":"BMJ"},{"issue":"7-8","key":"10.1016\/j.seizure.2016.01.020_bib0185","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1345\/aph.1P135","article-title":"L-carnitine for acute valproic acid overdose: a systematic review of published cases","volume":"44","author":"Perrott","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.seizure.2016.01.020_bib0190","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.020_bib0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","article-title":"Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy","volume":"69","author":"Mock","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.seizure.2016.01.020_bib0200","unstructured":"Lexi-Drugs Online, Valproic Acid. www.crlonine.com\/crlonline. Accessed Nov 2, 2015."},{"issue":"4","key":"10.1016\/j.seizure.2016.01.020_bib0205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.020_bib0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eplepsyres.2009.04.002","article-title":"The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status","volume":"86","author":"Hamed","year":"2009","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.seizure.2016.01.020_bib0215","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1345\/aph.1E063","article-title":"Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman","volume":"38","author":"Mallet","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.seizure.2016.01.020_bib0220","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/FTD.0b013e3182608e2f","article-title":"Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans","volume":"34","author":"Morand","year":"2012","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.020_bib0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/0883073808321060","article-title":"Serum and muscle carnitine levels in epileptic children receiving sodium valproate","volume":"24","author":"Anil","year":"2009","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1016\/j.seizure.2016.01.020_bib0230","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1528-1157.1998.tb01315.x","article-title":"L-carnitine supplementation in childhood epilepsy: current perspectives","volume":"39","author":"De Vivo","year":"1998","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2016.01.020_bib0235","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/hep.23891","article-title":"Polymerase \u03b3 gene POLG determines the risk of sodium valproate-induced liver toxicity","volume":"52","author":"Stewart","year":"2010","journal-title":"Hepatology."},{"issue":"15","key":"10.1016\/j.seizure.2016.01.020_bib0240","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/j.seizure.2016.01.020_bib0245","unstructured":"Lexi-Drugs Online, Carnitor (levocarnitine). www.crlonine.com\/crlonline. Accessed Nov 2, 2015."},{"key":"10.1016\/j.seizure.2016.01.020_bib0250","unstructured":"CPS Online, Carnitor (levocarnitine). www-e-therapeutics-ca.proxy2.lib.umanitoba.ca\/search. Accessed Nov 2, 2015."},{"key":"10.1016\/j.seizure.2016.01.020_bib0255","unstructured":"Product monograph. Carnitor (levocarnitine). Gaithersburg, MD; Sigma Tau Parmaceuticals, 2004. http:\/\/www.carnitor.com\/pdf\/CarnitorInjectionPI_2015_%2006-15_VPI-13.pdf. Accessed Nov 2, 2015."},{"key":"10.1016\/j.seizure.2016.01.020_bib0260","first-page":"eds","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. http:handbook.cochrane.org","volume":"28","author":"Higgins","year":"2015","journal-title":"Accessed June"},{"issue":"4","key":"10.1016\/j.seizure.2016.01.020_bib0265","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.seizure.2016.01.020_bib0270","unstructured":"Phillips B, Ball C, Sackett D, Straus S, Haynes B, Dawes M.;1; Oxford Centre for Evidence-Based Medicine Levels of Evidence. Version 2009. http:\/\/www.cebm.net\/?o=1025. Accessed June, 2015."},{"key":"10.1016\/j.seizure.2016.01.020_bib0275","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.020_bib0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1620\/tjem.167.89","article-title":"The effect of carnitine on the metabolism of valproic acid in epileptic patients","volume":"167","author":"Sakemi","year":"1992","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"10.1016\/j.seizure.2016.01.020_bib0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0887-8994(97)00211-7","article-title":"Effect of carnitine on valproic acid concentrations in serum, brain, and liver","volume":"18","author":"Sakemi","year":"1998","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2016.01.020_bib0295","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1528-1157.1984.tb03468.x","article-title":"Effects of SKF525A, phenobarbital, fasting, and carnitine on the anticonvulsant activity and neurotoxicity of valproate in mice","volume":"25","author":"Ater","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.020_bib0300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1749-6632.2001.tb03623.x","article-title":"The action of acetyl-L-carnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurones","volume":"939","author":"Virmani","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.seizure.2016.01.020_bib0305","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2015.08.044","article-title":"Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-l-carnitine","volume":"606","author":"Sarkar","year":"2015","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.020_bib0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1043-6618(05)80044-1","article-title":"Protective actions of L-carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors","volume":"32","author":"Virmani","year":"1995","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.seizure.2016.01.020_bib0315","first-page":"174","article-title":"L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction","volume":"1053","author":"Binienda","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.020_bib0320","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01250574","article-title":"Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo","volume":"86","author":"Janiri","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"issue":"7","key":"10.1016\/j.seizure.2016.01.020_bib0325","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00702-014-1170-x","article-title":"Antioxidants L-carnitine and D-methionine modulate neuronal activity through GABAergic inhibition","volume":"121","author":"Wu","year":"2014","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"10.1016\/j.seizure.2016.01.020_bib0330","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0028-3908(84)90033-9","article-title":"Transient seizure activity induced by acetylcarnitine","volume":"23","author":"Fariello","year":"1984","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.020_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y71-001","article-title":"The action of carnitines on cortical neurons","volume":"49","author":"Falchetto","year":"1971","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2016.01.020_bib0340","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuint.2012.06.008","article-title":"Dietary supplementation with acetyl-l-carnitine in seizure treatment of pentylenetetrazole kindled mice","volume":"61","author":"Smeland","year":"2012","journal-title":"Neurochem Int"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111600042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913111600042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:46:57Z","timestamp":1761011217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913111600042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"alternative-id":["S105913111600042X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.020","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levocarnitine induced seizures in patients on valproic acid: A negative systematic review","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}